Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term outcomes of intravesical heparin therapy for bladder pain syndrome
TCTR20180912004Phase 3Not yet recruiting
- Sponsor
- Siriraj Institutional Review Board
- Start
- Oct 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Siriraj Institutional Review Board. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
heparin
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on TCTR20180912004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180912004.